SilabTech Achieves First Silicon Success for Latest 28nm High-Speed, Mixed-Signal PHY Ips

Mentor Graphics Corp. today announced that SilabTech Pvt. Ltd. has achieved first silicon success for their latest 28nm high-speed, mixed-signal PHY IPs for PCI Express, SATA, MIPI, M-PHY and USB 3.0 in advance of the planned schedule.

SilabTech succeeded using the Mentor Graphics® Pyxis™, Eldo®, and Calibre® tools for custom layout, extraction, simulation, physical verification, and DFM analysis. The companies are also working in the post-silicon space to help characterize test chips, and to create a fully-compliant protocol certification platform using Mentor® FPGA and PCB tools.

SilabTech is a mixed-signal IP company specializing in analog-intensive designs that connect the digital world with the real world for multiple applications.

“With such a wide range of IC applications, SilabTech needs a tool flow that is both highly functional and supported by the world’s leading fabs,” said Sujoy Chakravarty, founder and CEO at SilabTech. “The advanced features of the Pyxis custom layout suite allow us to achieve best-in-class power and area quality of results, while verifying our designs with the Calibre Platform helps ensure that we will not have manufacturing surprises that could threaten our very aggressive design schedules.”

“Mentor Graphics is focused on our customers’ success,” said Walden Rhines, chairman and chief executive officer of Mentor Graphics. “So along with EDA software, we provide expertise that starts during early technology development with the world’s leading foundries. We can help our customers overcome technical challenges and help ensure they achieve their overall business goals.”

Source: http://www.mentor.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.